MT-0551

· Tanabe Pharma Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MT-0551, covering 2025-12-08 to 2025-12-08. Get the full timeline:

Most recent: Clinical Trial Update: A Study of MT-0551 in Patients With Systemic Sclerosis [Phase 3]